Microsure’s microsurgical robot technology enhances precision, stability, and control in microsurgery, enabling surgeons to perform complex operations with unprecedented accuracy. Here are details of Microsure‘s latest funding round :
🚀 Launch
2016
🏭 Industry
Medical equipment
🧠Management
Sjaak Deckers (CEO), Dick Dijkkamp (CTO)
💸 Funding & Investors
| INVESTMENT (October 2023) | €38 million (Series B2) |
| INVESTORS (October 2023) | European Innovation Council Fund (EICF), kineo, Invest-NL, and several prominent private investor groups. |
🎯 Funding purpose
Develop its latest microsurgical robot, MUSA-3, for clinical trials, followed by filing for FDA approval in the US and CE marking in Europe.
🌐 Country HQ
The Netherlands (Noord-Brabant)